John H. Edmonson
Mayo Clinic
Rochester
Minnesota 55905
USA
Name/email consistency: high
- Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor. Edmonson, J.H., Petersen, I.A., Shives, T.C., Mahoney, M.R., Rock, M.G., Haddock, M.G., Sim, F.H., Maples, W.J., O'Connor, M.I., Gunderson, L.L., Foo, M.L., Pritchard, D.J., Buckner, J.C., Stafford, S.L. Cancer (2002)
- Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas. Edmonson, J.H., Marks, R.S., Buckner, J.C., Mahoney, M.R. Cancer Invest. (2002)